Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
8.5 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | Wholesale prescription drug importation program; Sec. of Health and Human Resources to establish. | Secretary of Health and Human Resources; wholesale prescription drug importation program. Directs the Secretaryof Health and Human Resources to establish a wholesale prescriptiondrug importation program that complies with the requirements of federallaw and to report annually by October 1 to the Governor and the Chairmenof the House Committees on Appropriations and Health, Welfare andInstitutions and the Senate Committees on Finance and Appropriationsand Education and Health on the wholesale prescription drug importationprogram. The bill also requires the Secretary to (i) convene a workgroup composed of relevant stakeholders to develop a plan for implementationof the wholesale prescription drug importation program and reportthe plan to the Governor and the Chairmen of the House Committeeson Appropriations and Health, Welfare and Institutions and the SenateCommittees on Finance and Appropriations and Education and Healthby December 1, 2024, and (ii) seek such federal approvals, waivers, exemptions, or agreements as may be necessary to enable all coveredentities enrolled in or eligible for the federal 340B Drug PricingProgram to participate in the wholesale prescription drug importationprogram to the greatest extent possible without jeopardizing theireligibility for the 340B Drug Pricing Program by July 1, 2025. | us/states/va | Virginia General Assembly | 2024 | SB 186 | Virginia SB 186 (2024) |
|
enacted |
|
5 | 43 | 9 | 2024-01-08 | 2024-04-08 | openstates | ocd-bill/cf85edc3-7cdc-40f9-8ec9-10cdcb2d7d24 | https://lis.virginia.gov/cgi-bin/legp604.exe?241+sum+SB186 | c9cecd4084dc76b9b3bcd390c9143250224b995fd504c60dab5ac77bf5605fc7 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Virginia SB 186 (2024) — Wholesale prescription drug importation program; Sec. of Health and Human Resources to establish.
Secretary of Health and Human Resources; wholesale prescription drug importation program. Directs the Secretaryof Health and Human Resources to establish a wholesale prescriptiondrug importation program that complies with the requirements of federallaw and to report annually by October 1 to the Governor and the Chairmenof the House Committees on Appropriations and Health, Welfare andInstitutions and the Senate Committees on Finance and Appropriationsand Education and Health on the wholesale prescription drug importationprogram. The bill also requires the Secretary to (i) convene a workgroup composed of relevant stakeholders to develop a plan for implementationof the wholesale prescription drug importation program and reportthe plan to the Governor and the Chairmen of the House Committeeson Appropriations and Health, Welfare and Institutions and the SenateCommittees on Finance and Appropriations and Education and Healthby December 1, 2024, and (ii) seek such federal approvals, waivers, exemptions, or agreements as may be necessary to enable all coveredentities enrolled in or eligible for the federal 340B Drug PricingProgram to participate in the wholesale prescription drug importationprogram to the greatest extent possible without jeopardizing theireligibility for the 340B Drug Pricing Program by July 1, 2025.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- CHAP0620 (committee substitute) — source
- Committee substitute printed 24106622D-S1 (committee substitute) — source
- Committee substitute printed 24107494D-S2 (committee substitute) — source
- Prefiled and ordered printed; offered 01/10/24 24103007D (committee substitute) — source
- SB186ER (committee substitute) — source
Votes
- Reported from Rules (16-Y 0-N) — 16–0 (pass) · lower
- Constitutional reading dispensed (39-Y 0-N) — 39–0 (pass) · upper
- VOTE: Block Vote Passage (97-Y 0-N) — 96–0 (pass) · lower
- Reported from Appropriations (22-Y 0-N) — 22–0 (pass) · lower
- Subcommittee recommends reporting (6-Y 0-N) — 6–0 (pass) · lower
- Reported from Education and Health with substitute (15-Y 0-N) — 15–0 (pass) · upper
- Reported from Finance and Appropriations with substitute (15-Y 0-N) — 15–0 (pass) · upper
- Passed Senate (40-Y 0-N) — 40–0 (pass) · upper
- Constitutional reading dispensed (40-Y 0-N) — 40–0 (pass) · upper
Sponsors
- Suhas Subramanyam — primary (person)
- Adam P. Ebbin — cosponsor (person)
- Barbara A. Favola — cosponsor (person)
- Saddam Azlan Salim — cosponsor (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2024-01-08 Prefiled and ordered printed; offered 01/10/24 24103007D
filing, introduction - 2024-01-08 Referred to Committee on Education and Health
referral-committee - 2024-01-15 Impact statement from DPB (SB186)
- 2024-01-18 Assigned Education and Health Sub: Health
referral-committee - 2024-01-23 Senate subcommittee amendments and substitutes offered
- 2024-01-30 Senate subcommittee amendments and substitutes offered
- 2024-02-01 Reported from Education and Health with substitute (15-Y 0-N)
committee-passage - 2024-02-01 Committee substitute printed 24106622D-S1
substitution - 2024-02-01 Rereferred to Finance and Appropriations
referral-committee - 2024-02-05 Impact statement from DPB (SB186S1)
- 2024-02-08 Reported from Finance and Appropriations with substitute (15-Y 0-N)
committee-passage - 2024-02-08 Committee substitute printed 24107494D-S2
substitution - 2024-02-09 Impact statement from DPB (SB186S2)
- 2024-02-09 Constitutional reading dispensed (39-Y 0-N)
- 2024-02-12 Read second time
reading-2 - 2024-02-12 Education and Health Committee substitute rejected 24106622D-S1
- 2024-02-12 Reading of substitute waived
- 2024-02-12 Finance and Appropriations Committee substitute agreed to 24107494D-S2
substitution - 2024-02-12 Engrossed by Senate - committee substitute SB186S2
substitution - 2024-02-12 Constitutional reading dispensed (40-Y 0-N)
- 2024-02-12 Passed Senate (40-Y 0-N)
passage - 2024-02-15 Placed on Calendar
- 2024-02-15 Read first time
reading-1 - 2024-02-15 Referred to Committee on Rules
referral-committee - 2024-02-22 Assigned Rules sub: Studies Subcommittee
referral-committee - 2024-02-23 Subcommittee recommends reporting (6-Y 0-N)
- 2024-02-23 Subcommittee recommends referring to Committee on Appropriations
referral-committee - 2024-02-23 Reported from Rules (16-Y 0-N)
committee-passage - 2024-02-23 Referred to Committee on Appropriations
referral-committee - 2024-02-28 Reported from Appropriations (22-Y 0-N)
committee-passage - 2024-03-01 Read second time
reading-2 - 2024-03-04 Read third time
reading-3 - 2024-03-04 Passed House BLOCK VOTE (97-Y 0-N)
passage - 2024-03-04 VOTE: Block Vote Passage (97-Y 0-N)
passage - 2024-03-07 Enrolled
enrolled - 2024-03-07 Bill text as passed Senate and House (SB186ER)
passage - 2024-03-07 Signed by Speaker
passage - 2024-03-08 Impact statement from DPB (SB186ER)
- 2024-03-08 Signed by President
passage - 2024-03-11 Enrolled Bill Communicated to Governor on March 11, 2024
enrolled - 2024-03-11 Governor's Action Deadline 11:59 p.m., April 8, 2024
executive-receipt - 2024-04-08 Approved by Governor-Chapter 620 (effective 7/1/24)
executive-signature - 2024-04-08 Acts of Assembly Chapter text (CHAP0620)
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/cf85edc3-7cdc-40f9-8ec9-10cdcb2d7d24. Confidence: reported (aggregated from official Virginia legislature records).